🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
ICON Lenexa
Start Date
2024-05-09
Trial ID
NCT06394167
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
ICON Salt Lake City
Start Date
2024-01-04
Trial ID
NCT06226454
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
Shoals Medical Trials Inc.
Start Date
2024-10-29
Trial ID
NCT06619847
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
MAC Clinical Research
Start Date
2022-12-14
Trial ID
NCT05653323
The purpose of the study is to evaluate the routes and rate of elimination ...
Status
Completed
Location
Celerion - Lincoln
Start Date
2025-03-21
Trial ID
NCT06886269
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK), drug-dr...
Status
Completed
Location
MAC Clinical Research
Start Date
2024-05-02
Trial ID
NCT06392659
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Recruiting
Location
Cullman Clinical Trials
Start Date
2024-10-18
Trial ID
NCT06619860
Treatments Being Tested
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, ...
Status
Completed
Location
ICON Salt Lake City
Start Date
2024-07-26
Trial ID
NCT06508762
Treatments Being Tested
The purpose of this study is to determine the effects of Nav1.8 inhibition ...
Status
Completed
Location
MAC Clinical Research
Start Date
2024-05-21
Trial ID
NCT06420765
The purpose of this study is to evaluate the pharmacokinetic drug-drug inte...
Status
Completed
Location
ICON Salt Lake City
Start Date
2024-07-31
Trial ID
NCT06523595